Alector (ALEC) Cash from Operations (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Alector | 238.87 Mn | 32.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.48% |
| Dec 31, 2025 | -28.24% |
| Sep 30, 2025 | 33.71% |
| Jun 30, 2025 | 19.31% |
| Mar 31, 2025 | -10.46% |
| Dec 31, 2024 | -8.46% |
| Sep 30, 2024 | 19.21% |
| Jun 30, 2024 | -2.37% |
| Mar 31, 2024 | -33.16% |
| Dec 31, 2023 | 1.01% |
| Sep 30, 2023 | -8.22% |
| Jun 30, 2023 | 11.42% |
| Mar 31, 2023 | 0.77% |
| Dec 31, 2022 | 0.26% |
| Sep 30, 2022 | 14.60% |
| Jun 30, 2022 | -142.52% |
| Mar 31, 2022 | 374.21% |
| Dec 31, 2021 | -111.07% |
| Sep 30, 2021 | 1,099.15% |
| Jun 30, 2021 | 15.47% |
| Mar 31, 2021 | -10.56% |
| Dec 31, 2020 | -16.75% |
| Sep 30, 2020 | 11.15% |
| Jun 30, 2020 | -42.18% |
| Mar 31, 2020 | -12.09% |
| Dec 31, 2019 | 0.12% |
| Sep 30, 2019 | -59.89% |
| Jun 30, 2019 | 23.40% |
| Mar 31, 2019 | -33.49% |
| Dec 31, 2018 | 21.04% |
| Sep 30, 2018 | -31.15% |
| Jun 30, 2018 | -109.24% |